54 Participants Needed

Laparoscopic vs Robotic Surgery for Adrenalectomy

AP
KJ
Overseen ByKimberly Jenkins
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Cleveland Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

What data supports the effectiveness of the treatment Laparoscopic vs Robotic Lateral Transabdominal Adrenalectomy?

Studies show that both robotic and laparoscopic adrenalectomy have similar outcomes and complications, but robotic surgery may not offer significant advantages over the traditional laparoscopic approach. Laparoscopic posterior retroperitoneal adrenalectomy is noted to be more effective than the lateral transabdominal approach in terms of operation time and hospital stay.12345

Is robotic or laparoscopic adrenalectomy safe for humans?

Both robotic and laparoscopic adrenalectomy are considered safe for humans, with studies showing that the safety of robotic adrenalectomy has been widely demonstrated and is comparable to the conventional laparoscopic approach.13567

How does the treatment of laparoscopic vs robotic adrenalectomy differ from other treatments for adrenal gland conditions?

Laparoscopic adrenalectomy is the standard method for removing adrenal gland tumors, while robotic adrenalectomy is a newer option that offers similar outcomes but with potentially higher costs. The robotic approach may offer advantages in certain cases, but more cost reductions and technical advances are needed for it to become more widely used.12348

What is the purpose of this trial?

This study is being done to compare Laparoscopic vs Robotic lateral transabdominal adrenalectomy, these procedures are both standard of care.The study team would like to compare both patient outcomes and surgeon efficiency and perspectives among both procedures.The information from this study will help improve patient care, patient outcomes and maximize the appropriate utilization of resources in adrenal surgery.

Research Team

EB

Eren Berber, MD

Principal Investigator

The Cleveland Clinic

Eligibility Criteria

This trial is for individuals who require an adrenalectomy, a surgery to remove one or both adrenal glands. Participants should be suitable candidates for minimally invasive surgery but specific conditions that would exclude someone from participating are not listed.

Inclusion Criteria

I am diagnosed with an adrenal tumor and scheduled for a minimally invasive surgery at the Cleveland Clinic.

Exclusion Criteria

I am scheduled for a surgery to remove part of my adrenal gland.
I need surgery to remove my adrenal gland due to aggressive cancer.
I do not have any mental incapacity or language barriers that prevent understanding.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo either laparoscopic or robotic transabdominal adrenalectomy

1 day
1 visit (in-person)

Follow-up

Participants are monitored for postoperative outcomes including pain scores and hospital stay

3 days
1 visit (in-person)

Treatment Details

Interventions

  • Laparoscopic vs Robotic Lateral Transabdominal Adrenalectomy
Trial Overview The study compares two types of minimally invasive surgeries: laparoscopic and robotic lateral transabdominal adrenalectomy. It aims to evaluate patient outcomes and the efficiency and perspectives of surgeons using these methods.
Participant Groups
2Treatment groups
Active Control
Group I: 27 patients assigned to laparoscopic transabdominal adrenalectomyActive Control1 Intervention
Group II: 27 patients assigned to robotic transabdominal adrenalectomyActive Control1 Intervention

Laparoscopic vs Robotic Lateral Transabdominal Adrenalectomy is already approved in European Union, United States, Canada for the following indications:

πŸ‡ͺπŸ‡Ί
Approved in European Union as Laparoscopic Adrenalectomy for:
  • Adrenal tumors
  • Hyperaldosteronism
  • Cushing's syndrome
  • Pheochromocytoma
πŸ‡ΊπŸ‡Έ
Approved in United States as Robotic Adrenalectomy for:
  • Adrenal tumors
  • Hyperaldosteronism
  • Cushing's syndrome
  • Pheochromocytoma
πŸ‡¨πŸ‡¦
Approved in Canada as Minimally Invasive Adrenalectomy for:
  • Adrenal tumors
  • Hyperaldosteronism
  • Cushing's syndrome
  • Pheochromocytoma

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+

Findings from Research

In a study of 190 laparoscopic and 281 robotic adrenalectomies, robotic surgery resulted in shorter operative times and hospital stays, as well as less blood loss and fewer conversions to open surgery, particularly for pheochromocytoma and malignant tumors.
Both surgical methods had similar morbidity rates, suggesting that robotic adrenalectomy offers significant perioperative advantages without increasing the risk of complications.
Laparoscopic versus robotic lateral transabdominal adrenalectomy.Isiktas, G., Akgun, E., Berber, E.[2023]
Robotic adrenalectomy showed similar intraoperative times compared to conventional laparoscopic techniques for both lateral transabdominal and posterior retroperitoneal approaches, despite larger tumor sizes in the robotic group.
Patients undergoing robotic adrenalectomy experienced lower morbidity rates (2% vs 10%) and shorter hospital stays (1.1 days vs 1.5 days), indicating a potential safety and recovery advantage of the robotic approach.
Comparison of intraoperative time use and perioperative outcomes for robotic versus laparoscopic adrenalectomy.Karabulut, K., Agcaoglu, O., Aliyev, S., et al.[2022]
Robotic adrenalectomy (RA) is emerging as a viable option for adrenalectomy, alongside the standard laparoscopic approach (LA), as robotic technology becomes more widely adopted in medical centers.
This review highlights the need to evaluate the potential advantages of robotic adrenalectomy against its higher costs compared to laparoscopic adrenalectomy, although specific data on efficacy and safety were not detailed in the abstract.
Robotic lateral transabdominal adrenalectomy.Nomine-Criqui, C., Brunaud, L., Germain, A., et al.[2015]

References

Laparoscopic versus robotic lateral transabdominal adrenalectomy. [2023]
Comparison of intraoperative time use and perioperative outcomes for robotic versus laparoscopic adrenalectomy. [2022]
Robotic lateral transabdominal adrenalectomy. [2015]
Systematic Review of Surgical Approaches for Adrenal Tumors: Lateral Transperitoneal versus Posterior Retroperitoneal and Laparoscopic versus Robotic Adrenalectomy. [2022]
Robot-assisted versus conventional laparoscopic adrenalectomy: Results from the EUROCRINE Surgical Registry. [2022]
Robotic Adrenalectomy: A 10-Year Clinical Experience at a Tertiary Medical Center. [2022]
Robotic versus laparoscopic resection of large adrenal tumors. [2012]
8.China (Republic : 1949- )pubmed.ncbi.nlm.nih.gov
Robot assisted adrenalectomy: a handy tool or glorified obsession? [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceΒ·Privacy PolicyΒ·CookiesΒ·Security